Negative impact of clinical misdiagnosis of measles on health workers' confidence in measles vaccine

Epidemiology and Infection

Volumn 132, Issue 1, 2004, Pages 7-10

  Helfand, R F ^a   Chibi, T ^b   Biellik, R ^c   Shearley, A ^d   Bellini, W J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c WHO Regional Office for Africa   (Zimbabwe)

^d MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE; RUBELLA ANTIBODY;

ADOLESCENT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; COMMON COLD; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG EFFICACY; FEVER; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; RASH; RUBELLA; ZIMBABWE;

ADOLESCENT; ANTIBODIES, VIRAL; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DIAGNOSTIC ERRORS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INCIDENCE; INFANT; LABORATORY TECHNIQUES AND PROCEDURES; MEASLES; MEASLES VACCINE; MEASLES VIRUS; NEGATIVISM; PHYSICAL EXAMINATION; RUBELLA; RUBELLA VIRUS; RURAL HEALTH; SENSITIVITY AND SPECIFICITY; VACCINATION; ZIMBABWE;

EID: 1242352445     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803001547     Document Type: Article

References (16)

1. Halsey NA. The optimal age for administering measles vaccine in developing countries. In: Halsey NA, De Quadros C, eds. Recent advances in immunization. A bibliographic review 1983. Washington, DC: Pan American Health Organization, 4-17.
2. Mudzamiri WS, Petersen DE, Marufu T, Biellik RJ, L'Herminez M. Measles vaccine efficacy in Masvingo District, Zimbabwe. Cent Afr J Med 1996; 42: 195-197.
3. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull WHO 1985; 63: 1055-1068.
4. Dietz VJ, Nieburg P, Gubler DJ, Gomez I. Diagnosis of measles by clinical definition in dengue-endemic areas: implications for measles surveillance and control. Bull WHO 1992; 6: 745-750.
5. Helfand RF, Heath JL, Anderson LJ, Maes EF, Guris D, Bellini WJ. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis 1997; 175: 195-199.
6. Hummel K, Erdman DD, Heath J, Bellini WJ. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol 1992; 30: 2874-2880.
7. Redd SC, Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3rd ed. Philadelphia: W. B. Saunders Company, 1999: 222-266.
8. Black JB, Durigon E, Kite-Powell K, et al. Seroconversion to human herpesvirus 6 and human herpesvirus 7 among Brazilian children with clinical diagnoses of measles or rubella. Clin Infect Dis 1996; 23: 1156-1158.
9. Makhene MK, Diaz PS. Clinical presentations and complications of suspected measles in hospitalized children. Pediatr Infect Dis J 1993; 12: 836-840.
10. Cubel RCN, Siqueira MM, Santos EO, Pires MF, Cruz CM, Nascimento JP. Human parvovirus B19 infections among exanthematic diseases notified as measles. Rev Soc Bras Med Trop 1997; 30: 15-20.
11. Davidkin I, Valle M, Peltola H, et al. Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis 1998; 178: 1567-1570.
12. Tait DR, Ward KN, Brown DW, Miller E. Measles and rubella misdiagnosed in infants as exanthem subitum (roseola infantum). BMJ 1996; 312: 101-102.
13. Blackburn N, Schoub B, O'Connel K. Reliability of the clinical surveillance criteria for measles diagnosis. Bull WHO 2000; 78: 861.
14. Cutts F, Smith PG, Columbo S, Mann G, Ascherio A, Soares AC. Field evaluation of measles vaccine efficacy in Mozambique. Am J Epidemiol 1990; 131: 349-355.
15. Yamaguchi S, Dunga A, Broadhead RL, Brabin BJ. Epidemiology of measles in Blantyre, Malawi: analyses of passive surveillance data from 1996 to 1998. Epidemiol Infect 2002; 129: 361-369.
16. Biellik R, Madema A, Taole A, et al. First five years of experience with measles elimination in Southern Africa, 1996-2000. Lancet 2002; 359: 1564-1568.